TP53 and ovarian carcinoma: Similar to the results of the present study, no inactivating p53 germline mutations were found in any of Swedish familial breast cancer patients (Zelada-Hedman et al, 1997) or in German breast and/or ovarian cancer families (Balz et al, 2002).